The efficacy and safety of monoclonal antibody therapies for interstitial cystitis/bladder pain syndrome: A meta‐analysis of randomized controlled trials

Objectives This study aimed to assess the efficacy and safety of monoclonal antibody therapies (MATs) for interstitial cystitis/bladder pain syndrome (IC/BPS). Methods A systematic search was conducted across databases including PubMed, Embase, clinicalTrial.gov, and the Cochrane Library Central Reg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurourology and urodynamics 2024-11, Vol.43 (8), p.1903-1909
Hauptverfasser:	Cao, Zhi‐Gang, Li, Fu‐Dong, Zhang, Chun‐Lei, Luo, Guo‐Xiong, Chang, De‐Hui
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use autoimmunity Clinical trials Cystitis Cystitis, Interstitial - diagnosis Cystitis, Interstitial - drug therapy Cystitis, Interstitial - immunology Cystitis, Interstitial - physiopathology Humans Immunotherapy interstitial cystitis/bladder pain syndrome Meta-analysis Monoclonal antibodies monoclonal antibody NGF Odds Ratio Pain Pain Measurement Randomized Controlled Trials as Topic Statistical analysis TNF‐α Treatment Outcome Urination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!